Literature DB >> 16672439

Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.

Javier Pemán1, Isidro Jarque, María Bosch, Emilia Cantón, Miguel Salavert, Rosario de Llanos, Araceli Molina.   

Abstract

A 62-year-old man with amphotericin B-resistant Candida krusei spondylodiscitis, following an episode of candidemia caused by the same strain, was successfully treated with caspofungin plus voriconazole. Amphotericin B fungicidal concentrations were better predictors of the clinical outcome than were MICs. This is the first case of C. krusei spondylodiscitis reported in the literature.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16672439      PMCID： PMC1479197          DOI： 10.1128/JCM.44.5.1912-1914.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Another patient with candida vertebral osteomyelitis treated with liposomal amphotericin B.

Authors:  Lawrence A Cone; Luke Dreisbach; Phillip Dreisbach; Moxelle Wuesthoff
Journal:  Surg Neurol       Date:  2005-06

Review 2.  Vertebral osteomyelitis due to Candida species: case report and literature review.

Authors:  D J Miller; G C Mejicano
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

Review 3.  Candidal vertebral osteomyelitis: report of 6 patients, and a review.

Authors:  L Hendrickx; E Van Wijngaerden; I Samson; W E Peetermans
Journal:  Clin Infect Dis       Date:  2001-02-06       Impact factor: 9.079

4.  Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species.

Authors:  Emilia Cantón; Javier Pemán; Angel Viudes; Guillermo Quindós; Miguel Gobernado; Ana Espinel-Ingroff
Journal:  Diagn Microbiol Infect Dis       Date:  2003-03       Impact factor: 2.803

5.  Spondylodiscitis due to Candida tropicalis as a cause of inflammatory back pain.

Authors:  G D Sebastiani; F Galas
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

6.  Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole).

Authors:  G Petrikkos; A Skiada; H Sabatakou; A Antoniadou; T Dosios; H Giamarellou
Journal:  Mycoses       Date:  2001-11       Impact factor: 4.377

7.  Spondylodiscitis and epidural abscess due to Candida albicans.

Authors:  P Derkinderen; F Bruneel; O Bouchaud; B Regnier
Journal:  Eur Spine J       Date:  2000-02       Impact factor: 3.134

8.  Candida glabrata spinal osteomyelitis involving two contiguous lumbar vertebrae: a case report and review of the literature.

Authors:  Laurent Seravalli; Daniel Van Linthoudt; Christian Bernet; Antoine de Torrenté; Oscar Marchetti; François Porchet; Daniel Genné
Journal:  Diagn Microbiol Infect Dis       Date:  2003-02       Impact factor: 2.803

9.  Candida albicans spondylodiscitis.

Authors:  L F Ugarriza; J M Cabezudo; L M Lorenzana; J A Rodríguez-Sánchez
Journal:  Br J Neurosurg       Date:  2004-04       Impact factor: 1.596

10.  Patterns of amphotericin B killing kinetics against seven Candida species.

Authors:  Emilia Cantón; Javier Pemán; Miguel Gobernado; Angel Viudes; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
View more
  6 in total

1.  Successful treatment of Candida discitis with 5-flucytosine and fluconazole.

Authors:  Satish M Rachapalli; Ritu Malaiya; T A M T Mohd; Rod A Hughes
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

2.  'Fungal spondylodiscitis in a non-immunocompromised patient'.

Authors:  Vanda Cristina Jorge; Catarina Cardoso; Carla Noronha; José Simões; Nuno Riso; Manuel Vaz Riscado
Journal:  BMJ Case Rep       Date:  2012-03-08

Review 3.  Fungal spondylodiscitis in a patient recovered from H7N9 virus infection: a case study and a literature review of the differences between Candida and Aspergillus spondylodiscitis.

Authors:  Lie-Dao Yu; Zhi-Yun Feng; Xuan-Wei Wang; Zhi-Heng Ling; Xiang-Jin Lin
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

4.  Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy.

Authors:  Theodoros Kelesidis; Kelesidis Theodoros; Sotirios Tsiodras; Tsiodras Sotirios
Journal:  Rheumatol Int       Date:  2011-09-03       Impact factor: 2.631

Review 5.  Talus osteomyelitis by Candida krusei with multiple huge cystic lesions: a case report and review of literatures.

Authors:  Hyungtae Kim; Su-Young Bae
Journal:  BMC Musculoskelet Disord       Date:  2022-07-19       Impact factor: 2.562

6.  Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; E Nagy; S Dobiasova; M Rinaldi; R Barton; A Veselov
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.